Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

Metastatic uveal melanoma (UM) is a poor prognosis malignancy. Immunotherapy is commonly employed, despite the low activity, considering the lack of other effective systemic treatments. In this study, the prognostic and predictive role of soluble immune checkpoints and inflammatory cytokines/chemoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Ernesto, Zizzari, Ilaria Grazia, Di Filippo, Alessandra, Acampora, Anna, Pagliara, Monica Maria, Sammarco, Maria Grazia, Simmaco, Maurizio, Lionetto, Luana, Botticelli, Andrea, Bria, Emilio, Marchetti, Paolo, Blasi, Maria Antonietta, Tortora, Giampaolo, Schinzari, Giovanni, Nuti, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Melanoma Immunotherapy SF – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302506/
https://www.ncbi.nlm.nih.gov/pubmed/35258435
http://dx.doi.org/10.1080/21645515.2022.2034377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302506/
https://www.ncbi.nlm.nih.gov/pubmed/35258435
http://dx.doi.org/10.1080/21645515.2022.2034377

Ejemplares similares